On the whereabouts of SARS-CoV-2 in the human body : A systematic review
Since SARS-CoV-2 appeared in the human population, the scientific community has scrambled to gather as much information as possible to find good strategies for the containment and treatment of this pandemic virus. Here, we performed a systematic review of the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids. In addition, this evidence is aligned with published ACE2 entry-receptor (single cell) expression data across the human body to construct a viral distribution and ACE2 receptor body map. We highlight the broad organotropism of SARS-CoV-2, as many studies identified viral components (RNA, proteins) in multiple organs, including the pharynx, trachea, lungs, blood, heart, vessels, intestines, brain, male genitals and kidneys. This also implicates the presence of viral components in various body fluids such as mucus, saliva, urine, cerebrospinal fluid, semen and breast milk. The main SARS-CoV-2 entry receptor, ACE2, is expressed at different levels in multiple tissues throughout the human body, but its expression levels do not always correspond with SARS-CoV-2 detection, indicating that there is a complex interplay between virus and host. Together, these data shed new light on the current view of SARS-CoV-2 pathogenesis and lay the foundation for better diagnosis and treatment of COVID-19 patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
PLoS pathogens - 16(2020), 10 vom: 30. Okt., Seite e1009037 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Trypsteen, Wim [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antiviral Agents |
---|
Anmerkungen: |
Date Completed 01.12.2020 Date Revised 04.11.2023 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1371/journal.ppat.1009037 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316939404 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316939404 | ||
003 | DE-627 | ||
005 | 20231225162153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1371/journal.ppat.1009037 |2 doi | |
028 | 5 | 2 | |a pubmed24n1056.xml |
035 | |a (DE-627)NLM316939404 | ||
035 | |a (NLM)33125439 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Trypsteen, Wim |e verfasserin |4 aut | |
245 | 1 | 0 | |a On the whereabouts of SARS-CoV-2 in the human body |b A systematic review |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.12.2020 | ||
500 | |a Date Revised 04.11.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Since SARS-CoV-2 appeared in the human population, the scientific community has scrambled to gather as much information as possible to find good strategies for the containment and treatment of this pandemic virus. Here, we performed a systematic review of the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids. In addition, this evidence is aligned with published ACE2 entry-receptor (single cell) expression data across the human body to construct a viral distribution and ACE2 receptor body map. We highlight the broad organotropism of SARS-CoV-2, as many studies identified viral components (RNA, proteins) in multiple organs, including the pharynx, trachea, lungs, blood, heart, vessels, intestines, brain, male genitals and kidneys. This also implicates the presence of viral components in various body fluids such as mucus, saliva, urine, cerebrospinal fluid, semen and breast milk. The main SARS-CoV-2 entry receptor, ACE2, is expressed at different levels in multiple tissues throughout the human body, but its expression levels do not always correspond with SARS-CoV-2 detection, indicating that there is a complex interplay between virus and host. Together, these data shed new light on the current view of SARS-CoV-2 pathogenesis and lay the foundation for better diagnosis and treatment of COVID-19 patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Systematic Review | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Receptors, Virus |2 NLM | |
650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
650 | 7 | |a EC 3.4.15.1 |2 NLM | |
700 | 1 | |a Van Cleemput, Jolien |e verfasserin |4 aut | |
700 | 1 | |a Snippenberg, Willem van |e verfasserin |4 aut | |
700 | 1 | |a Gerlo, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Vandekerckhove, Linos |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t PLoS pathogens |d 2005 |g 16(2020), 10 vom: 30. Okt., Seite e1009037 |w (DE-627)NLM158124782 |x 1553-7374 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2020 |g number:10 |g day:30 |g month:10 |g pages:e1009037 |
856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.ppat.1009037 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2020 |e 10 |b 30 |c 10 |h e1009037 |